Zydus gets USFDA nod for Dexamethasone Tablets USP, 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg and Dexamethasone Tablets USP, 2 mg Read more
Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US Read more
Sentynl completes asset transfer of CUTX-101 Copper Histidinate product candidate for treatment of Menkes Disease from Cyprium Read more
Zydus NCE drugs will see improved market penetration with new partnerships in India: GlobalData Read more